{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:18:12Z","timestamp":1794359892081,"version":"4.9.0"},"reference-count":31,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Patients with ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD) who undergo complete revascularization (CR) have a more favorable prognosis than those who receive incomplete revascularization (IR), as evidenced by recent randomized controlled trials. Despite the absence of a survival benefit associated with CR in these trials, positive outcomes were ascribed to combined endpoints, such as repeat revascularization, myocardial infarction, or ischemia-driven rehospitalization. In light of the significant burden that rehospitalization from STEMI imposes on healthcare systems, we examined the long-term effects of CR on ischemia-driven rehospitalization and cardiovascular (CV) mortality in STEMI patients with MVD. Methods: In our retrospective study, we included patients with STEMI and MVD who underwent successful primary percutaneous coronary intervention (PCI) at the University Medical Centre Ljubljana between 1 January 2009, and 11 April 2011. The combined endpoint was ischemia-driven rehospitalization and CV mortality, with a minimum follow-up period of six years. Results: We included 235 participants who underwent CR (N = 70) or IR (N = 165) at index hospitalization, with a median follow-up time of 7 years (interquartile range 6.0\u20138.2). The primary endpoint was significantly higher in the IR group than in the CR group (47.3% vs. 32.9%, log-rank p = 0.025), driven by CV mortality (23.6% vs. 12.9%, log-rank p = 0.047), as there was no difference in ischemia-driven rehospitalization rate (log-rank p = 0.206). Ischemia-driven rehospitalization did not influence CV mortality in the CR group (p = 0.49), while it significantly impacted CV mortality in the IR group (p = 0.03). After adjusting for confounders, there were no differences in CV mortality between CR and IR groups (p = 0.622). Predictors of the combined endpoint included age (p = 0.014), diabetes (p = 0.006), chronic kidney disease (CKD) (p = 0.001), cardiogenic shock at presentation (p = 0.003), chronic total occlusion (CTO) (p = 0.046), and ischemia-driven rehospitalization (p = 0.0001). Significant risk factors for the combined endpoint were cardiogenic shock at presentation (p &lt; 0.001), stage 4 kidney failure (p = 0.001), age over 70 years (p = 0.004), female gender (p = 0.008), and residual SYNTAX I score &gt; 5.5 (p = 0.017). Conclusions: Patients with STEMI and MVD who underwent CR had a lower combined endpoint of ischemia-driven rehospitalizations and CV mortality than IR patients, but after adjustments for confounders, the true determinants of the combined endpoint and risk factors for the combined endpoint were independent of the revascularization method.<\/jats:p>","DOI":"10.3390\/jcm14134793","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:58:23Z","timestamp":1751878703000},"page":"4793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Complete Revascularization in STEMI: Ischemia-Driven Rehospitalization and Cardiovascular Mortality"],"prefix":"10.3390","volume":"14","author":[{"given":"Miha","family":"Sustersic","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Medical Centre Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-8944","authenticated-orcid":false,"given":"Matjaz","family":"Bunc","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia"},{"name":"Institute of Pathological Physiology, Medical Faculty, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","article-title":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"28","author":"Sorajja","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjcard.2009.04.016","article-title":"Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)","volume":"104","author":"Cavender","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcin.2009.10.017","article-title":"Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease","volume":"3","author":"Hannan","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCOUTCOMES.114.001194","article-title":"Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: Real-world analysis of 3984 patients in London","volume":"7","author":"Iqbal","year":"2014","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcin.2016.10.024","article-title":"Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease","volume":"10","author":"Iqbal","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete Revascularization with Multivessel PCI for Myocardial Infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal Medical Therapy with or without PCI for Stable Coronary Disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jcmg.2020.08.030","article-title":"NIRS-IVUS for Differentiating Coronary Plaque Rupture, Erosion, and Calcified Nodule in Acute Myocardial Infarction","volume":"14","author":"Terada","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kuku, K.O., Singh, M., Ozaki, Y., Dan, K., Chezar-Azerrad, C., Waksman, R., and Garcia-Garcia, H.M. (2020). Near-Infrared Spectroscopy Intravascular Ultrasound Imaging: State of the Art. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00107"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e008768","DOI":"10.1161\/CIRCINTERVENTIONS.119.008768","article-title":"Nonculprit Lesion Plaque Morphology in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys","volume":"13","author":"Mehta","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jcin.2020.02.030","article-title":"Evaluation and Management of Nonculprit Lesions in STEMI","volume":"13","author":"Thim","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5334\/gh.1040","article-title":"Complete Revascularization and Survival in STEMI","volume":"16","author":"Sustersic","year":"2021","journal-title":"Glob. Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e000541","DOI":"10.1136\/openhrt-2016-000541","article-title":"Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: An observational study","volume":"4","author":"Hermans","year":"2017","journal-title":"Open Heart"},{"key":"ref_22","first-page":"425","article-title":"Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry","volume":"70","year":"2017","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_23","first-page":"214","article-title":"Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularisation versus conservative strategy. Prague-13 trial","volume":"17","author":"Hlinomaz","year":"2015","journal-title":"Kardiol. Rev. Int. Med."},{"key":"ref_24","first-page":"CD011986","article-title":"Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease","volume":"5","author":"Bravo","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4244\/EIJV10I1A12","article-title":"Validation of residual SYNTAX score with second-generation drug-eluting stents: One-year results from the prospective multicentre SEEDS study","volume":"10","author":"Xu","year":"2014","journal-title":"EuroIntervention"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ahmed, T.A.N., Othman, A.A.A., Demitry, S.R., and Elmaghraby, K.M. (2024). Impact of residual coronary lesions on outcomes of myocardial infarction patients with multi-vessel disease. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03657-2"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9245431","DOI":"10.1155\/2020\/9245431","article-title":"Prognostic Value of the Residual SYNTAX Score on In-Hospital and Follow-Up Clinical Outcomes in ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions","volume":"2020","author":"Altekin","year":"2020","journal-title":"Cardiol. Res. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e009863","DOI":"10.1161\/JAHA.118.009863","article-title":"Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010\u20132014","volume":"7","author":"Kim","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e005926","DOI":"10.1161\/JAHA.117.005926","article-title":"Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized Trial","volume":"6","author":"Spitzer","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/clc.22156","article-title":"Predicting readmission or death after acute ST-elevation myocardial infarction","volume":"36","author":"Brown","year":"2013","journal-title":"Clin. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.4244\/EIJ-D-24-00814","article-title":"Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: A systematic review and network meta-analysis","volume":"21","author":"Laudani","year":"2025","journal-title":"EuroIntervention"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:05:54Z","timestamp":1760033154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":31,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14134793"],"URL":"https:\/\/doi.org\/10.3390\/jcm14134793","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}